Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

HUMEGON

MENOTROPINS (FSH;LH)

Standard Dose
75 IU/VIAL;75 IU/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview HUMEGON is listed in Drugs@FDA under application 020328 (BLA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient MENOTROPINS (FSH;LH) Form and strength INJECTABLE;INJECTION - 75 IU/VIAL;75 IU/VIAL Sponsor ORGANON USA INC Submission history Latest submission status date: 1999-11-23 00:00:00.

Structured Monograph

Clinical summary

Approval overview HUMEGON is listed in Drugs@FDA under application 020328 (BLA). Review priority: STANDARD Marketing status: Discontinued Active ingredient MENOTROPINS (FSH;LH) Form and strength INJECTABLE;INJECTION - 75 IU/VIAL;75 IU/VIAL Sponsor ORGANON USA INC Submission history Latest submission status date: 1999-11-23 00:00:00. Submission type: SUPPL.

Monitoring

  • Marketing status: Discontinued
  • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
HUMEGON (MENOTROPINS (FSH;LH)) | Drug Monograph | MedicHelpline